XOMA:
Analysis & Opinions
-
June 17, 2013
XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory ...
-
January 02, 2013
XOMA Corporation (XOMA) recently announced that it intends to include active non-infectious anterior scleritis in ...
-
November 26, 2012
XOMA Corporation (XOMA) recently announced encouraging data from a phase III study PATH (Perindopril Amlodipine for ...
-
August 23, 2012
XOMA Corporation's (XOMA) gevokizumab recently received Orphan Drug Designation from the US Food & Drug ...
-
July 06, 2012
XOMA Corporation (XOMA) recently announced that it has initiated patient enrollment in two trials being conducted ...
-
September 02, 2011
XOMA changes management again, but should anybody care?
-
August 27, 2010
The fragile U.S. economy seems to be headed for the inevitable double dip, as a slew of recent data raise concerns ...
